Key result
Surgery treats acute bioprosthetic aortic regurgitation, with ~6% of associated endocarditis cases lacking identified pathogens.
Why the study?
Acute bioprosthetic aortic valve regurgitation can cause cardiogenic shock and requires critical assessment and treatment strategies.
Highlights the critical role of echocardiography and surgery in managing acute bioprosthetic aortic valve regurgitation, which can present as cardiogenic shock.
Answers are grounded in this paper and cite their sources.
Consider acute bioprosthetic aortic regurgitation in cardiogenic shock; single case leaves open generalizability of surgical treatment.
•Acute bioprosthetic aortic valve regurgitation can present with cardiogenic shock.•Echocardiography is critical in the assessment of bioprosthetic aortic valve function.•In up to 6% of patients with infectious endocarditis, no microbiologic agent is identified.•Surgery is the mainstay of treatment for prosthetic acute aortic regurgitation.
No takes yet. Share an insight, caveat, or question.
Milioglou et al. (2022) studied this question. Acute bioprosthetic aortic valve regurgitation requires surgery as the mainstay of treatment, and associated infectious endocarditis lacks an identified pathogen in up to 6% of cases.
Synapse has enriched 10 related papers. Consider them for comparative context: